Glaukos Corp to Discuss the FDA Approval of iDose TR Transcript
Good morning and welcome to the Glaukos Corporation's conference call to discuss FDA approval of Eidos Tiara. Copies of the Company's press release are available at www.glaukos.com. This call is being recorded and an archived replay will be available online in the Investor Relations section at www.glaukos.com. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. If you'd like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question again press the star one. I would now like to turn the call over to Chris Lewis, Vice President of Investor Relations, and Corporate Affairs. You may begin your conference.
Thank you and good morning. Joining me today are Bob Best, Chairman
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |